Clinical trial Recruiting at 1 site Observational

Observational study on a new type of implantable defibrillator

Official title: French COhoRte Extra-Vascular Implantable CardiovErter DefibrillatoR

Run by Paris Sudden Death Expertise Center · NCT06739239 · Data updated 2026-11-12

This study looks at a new type of implantable defibrillator to see how well it works in preventing sudden cardiac death in patients who are at high risk.

Quick facts

Study typeObservational
SexAll
Enrollment1000 (estimated)
SponsorParis Sudden Death Expertise Center
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedFebruary 1, 2024
Main results expectedDecember 31, 2030
Study endsDecember 31, 2030
Registry record updatedDecember 20, 2024
Trial IDNCT06739239 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients who are undergoing implantation of an extravascular implantable cardioverter-defibrillator.

Probably not a fit

Patients who refuse consent for participation will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the extravascular implantable cardioverter-defibrillator (EV-ICD), which is designed to reduce the risk of sudden cardiac death in high-risk patients. The EV-ICD features a lead positioned in the substernal space, allowing for advanced pacing and defibrillation capabilities. While previous studies have shown that EV-ICDs can be safely implanted and effectively terminate ventricular arrhythmias, this study aims to gather more extensive follow-up data from a broader patient population. The study is observational, meaning it will monitor outcomes without assigning specific interventions.

Why it matters

Potential benefit: If successful, this study could lead to improved outcomes for patients at risk of sudden cardiac death through enhanced defibrillator technology.

How similar studies have gone: Previous studies have shown that EV-ICDs can be safely implanted and are effective, but this study aims to expand on limited follow-up data from selected centers.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients undergoing EV-ICD implantation

Exclusion Criteria:

* Refusal of consent

Where it's running

  • European Georges Pompidou Hospital
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.